## How Immunotherapy Is Revolutionizing Cancer Treatment and Beyond

Over the past decade, clinical trials exploring immunotherapy have surged dramatically, as scientists have translated deep knowledge of the human immune system into groundbreaking medical treatments. While cancer therapies remain at the forefront of this revolution, researchers are rapidly expanding the scope of immunotherapy to address a wide spectrum of conditions — including infections, allergies, neurological diseases, and autoimmune disorders.

## What Exactly Is Immunotherapy?

Immunotherapy refers to a category of biological treatments designed to harness, guide, or modify the immune system to prevent and fight disease. Vaccines are perhaps the most widely recognized form — they teach the immune system to identify and respond to specific threats, such as viruses or bacteria. Beyond vaccines, some immunotherapies work by amplifying immune responses that are too weak to combat illness effectively, while others suppress overactive immune reactions that cause the body to attack itself. Additional approaches leverage engineered immune cells or laboratory-produced antibodies to intervene in disease processes at a molecular level.

Although the concept of strengthening the body's defenses to ward off disease has ancient roots, sophisticated immunotherapies targeting a broad range of conditions have only truly emerged in the last two decades. A global clinical trials registry recorded 1,257 immunotherapy trials between 2006 and 2016 — a number that surged to 4,591 in the following decade alone.

"It's really exciting. People are starting to realise just how important the immune system is," says Adrian Liston, an immunologist and professor of pathology at the University of Cambridge. "This is the era of immunology."

## Immunotherapy and Cancer: A Paradigm Shift

Cancer patients have been among the greatest beneficiaries of immunotherapy advances. Dozens of approved treatments now exist for more than 30 types of cancer. One key challenge in treating cancer is that many tumors actively evade the immune system by effectively switching off the immune cells sent to destroy them. A class of antibody-based drugs known as checkpoint inhibitors can reverse this process, reactivating immune cells so they can once again identify and attack malignant tissue. Highly mutated cancers like melanoma tend to respond especially well to this approach, though outcomes vary significantly from patient to patient.

Understanding why some patients respond powerfully to immunotherapy while others see little benefit is a major research priority. A newly launched four-year study aims to recruit thousands of patients with breast, bladder, kidney, and skin cancers to identify the key factors that determine treatment outcomes.

### Antibody-Based Therapies and Cancer Vaccines

Not all antibody-based cancer therapies work through checkpoint inhibition. The drug Herceptin, for example, attaches directly to breast and stomach tumors, flagging them for immune destruction while simultaneously blocking chemical signals that would otherwise stimulate tumor growth.

Cancer vaccines represent another area of enormous promise. Drawing on the same mRNA technology platform that powered the COVID-19 vaccines, more than 100 cancer vaccines are currently being evaluated in clinical trials. These vaccines are designed to prime the immune system to seek out and destroy tumor cells.

### Engineering Immune Cells to Fight Cancer

Researchers are also exploiting immune cells directly in their fight against cancer. In a landmark 2018 case, doctors treated a woman with metastatic breast cancer by extracting immune cells that had naturally infiltrated her tumors, cultivating billions of those cells in laboratory conditions, and then reintroducing the most effective ones back into her body.

Another powerful approach, known as CAR-T-cell therapy, involves genetically engineering a patient's own immune cells to specifically target and eliminate cancer cells. The therapy gained public attention recently when actor Sam Neill — best known for his role in Jurassic Park — announced he had been declared cancer-free following CAR-T-cell treatment for stage 3 blood cancer as part of a clinical trial.

"We increasingly see cancer as something that's shaped by the immune system," says Samra Turajlić, director of the Cancer Research UK Manchester Institute and head of the cancer dynamics laboratory at the Francis Crick Institute in London. "In fact, the appearance of cancer is a failure of the immune system to eliminate it in the first place."

## Beyond Cancer: Treating Allergies, Depression, and Autoimmune Disease

While cancer immunotherapies generally aim to intensify immune activity, therapies for many other conditions work in the opposite direction — calming an overactive immune response.

Allergy treatments, for instance, work by gradually exposing patients to tiny, incrementally increasing doses of the proteins responsible for their allergic reactions. This desensitization approach is used for conditions ranging from hay fever to peanut intolerance. A recent clinical trial in China even explored whether feeding patients pancakes could help alleviate egg allergies.

Researchers are also investigating whether existing immunotherapies originally developed for one condition might benefit patients with entirely different diagnoses. A team in Bristol recently trialed tocilizumab — an immunotherapy drug approved for rheumatoid arthritis — in patients suffering from depression. Although the study was limited in size, early results hinted at improvements in depression severity, fatigue, anxiety, and overall quality of life.

## The Rise of Regulatory T-Cell Therapies

Some of the most exciting developments in immunotherapy stem from research that earned last year's Nobel Prize — specifically, work centered on regulatory T-cells, commonly referred to as Tregs. While the immune system contains many different cell types dedicated to attacking pathogens, Tregs perform a unique function: they signal the immune system to stand down once a threat has been neutralized.

Adrian Liston, who co-founded a Cambridge-based biotech startup called Aila Biotech, is currently developing a Treg-based therapy for multiple sclerosis — a condition in which immune cells mistakenly attack the body's own nervous system. His team's approach aims to boost Treg activity within the brain to halt this self-destructive immune assault. The same mechanism, he notes, could potentially be applied to reduce dangerous swelling following traumatic brain injury.

### A New Frontier for Tregs

The therapeutic potential of Treg-based treatments extends well beyond multiple sclerosis. Treatments targeting Tregs are currently in development for dementia, type 1 diabetes, rheumatoid arthritis, lupus, and chronic inflammation. At Monash University, researcher Peter Eggenhuizen is developing a Treg therapy specifically designed to treat inflammatory bowel disease — a condition that affects at least 7 million people worldwide.

## The Immune System: Medicine's Next Great Frontier

"Probably half of all deaths have a component that is immunological," says Liston. "It is an underlying theme across ageing, autoimmune diseases, allergies, infectious diseases, inflammatory diseases like diabetes. But one of the great things about the immune system is that it is very easy to change. We can adapt it to our purposes."

As clinical trials continue to multiply and our understanding of immune biology deepens, immunotherapy stands poised to redefine what is medically possible — offering new hope to millions of patients across a vast range of conditions that were once considered difficult or impossible to treat.

Discover how immunotherapy is transforming cancer treatment and offering new hope for allergies, autoimmune disorders, and neurological diseases worldwide.

How Immunotherapy Is Changing Cancer Treatment

large_1350.jpg

medium_1350.jpg

small_1350.jpg

thumbnail_1350.jpg

1350.jpg

How Immunotherapy Is Revolutionizing Cancer Treatment and Beyond

## The Stress Conversation We Keep Getting Wrong

A recent article exploring what stress does to the human body offered valuable physiological insight — but it stopped well short of addressing the full picture. By focusing on familiar everyday irritants like chaotic school runs, online spats, misplaced belongings, and late-night scrolling habits, it framed chronic stress as largely a personal management challenge. The proposed remedies followed the same logic: breathe better, ruminate less, build resilience, exercise more, practice self-care.

This framing, while not entirely wrong, is dangerously incomplete.

## Stress Is Being Produced by the System, Not Just by Your Morning Routine

The uncomfortable truth is that much of the chronic stress people carry today is not generated by minor daily frustrations. It is manufactured by the structural and cultural conditions of modern life itself — conditions that have quietly become psychologically toxic over time.

Social atomisation, financial precarity, the relentless demands of platform-based digital culture, transactional relationships, and the steady erosion of genuine community life are among the primary architects of widespread psychological strain. These are not problems that a breathing exercise can dismantle.

Growing numbers of people are experiencing daily life not as something that sustains or nourishes them, but as something that depletes and extracts from them. They feel invisible, undervalued, emotionally unsupported, easily replaceable, and perpetually switched on — unable to truly rest or disconnect. This is not a mindset problem. It is a conditions problem.

## The Sleight of Hand in Modern Wellness Culture

Contemporary discourse around mental health and stress management often performs a subtle but significant misdirection. It repackages what is fundamentally a social and cultural crisis as a personal resilience deficit — something to be quietly corrected through individual effort and self-optimization.

In doing so, it leaves the root causes almost entirely unexamined. The social systems generating widespread distress remain intact, while individuals are encouraged to work harder at managing the symptoms those systems produce.

This is not a neutral framing. It shifts responsibility away from collective and structural accountability and places it squarely on the shoulders of already-exhausted individuals.

## Individual Tools Have Their Place — But They Are Not the Whole Answer

None of this is an argument against therapeutic techniques. Mindfulness, regulated breathing, physical exercise, and professional therapy all carry genuine value. In moments of acute physiological stress activation, these tools can provide meaningful relief and help restore a sense of calm.

But they are downstream interventions — responses to symptoms rather than remedies for causes.

They cannot substitute for the things human beings actually need to thrive: a sense of meaning and purpose, economic stability, mutual recognition, emotional reciprocity, genuine affection, and the experience of belonging to a real community.

## Reframing the Conversation

Addressing the stress epidemic properly requires expanding the frame of the conversation beyond individual coping strategies. It requires honest examination of the social, economic, and cultural conditions that have made so many people feel that life is something happening *to* them rather than *with* them.

Until that conversation becomes central rather than peripheral, stress management will remain what it too often is today — a personal burden handed back to those already struggling most under its weight.

Chronic stress isn't just about busy mornings or doomscrolling. Discover how deeper social and cultural forces are driving a widespread psychological crisis.

Why Modern Life Itself Is Making Us More Stressed

large_5000.jpg

medium_5000.jpg

small_5000.jpg

thumbnail_5000.jpg

5000.jpg

Why Modern Life Itself Is the Stress Problem — Not Just Your Daily Habits

## Former World Leaders Rehearse the Next Global Health Crisis in Nairobi

Imagine sitting in a boardroom in Nairobi, watching a fictional bird flu outbreak unfold in Chad — and being asked, as a former head of state, exactly what you would do about it. That was the reality last Thursday for a distinguished gathering of retired world leaders, Nobel laureates, and diplomats who assembled at a World Health Organization facility just outside the Kenyan capital.

The exercise was organized under the banner of the Elders, a group founded in 2007 by the late Nelson Mandela. The organization brings together a curated selection of former presidents, prime ministers, and senior global figures with the shared mission of applying their combined experience to the world's most pressing problems.

---

## A Simulated Outbreak With Very Real Lessons

The scenario was deliberately challenging. Health workers in eastern Chad had detected several unexplained deaths linked to respiratory failure. Early testing pointed to a novel strain of avian influenza, though confirmation required sending samples abroad. Under international health regulations, Chad's government was obligated to notify the WHO within 24 hours — but officials were reluctant, worried about economic backlash and international stigma.

The question put to the assembled leaders was pointed: if you were Chad's president, how would you ensure your health minister followed the rules, and what guarantees would you demand from the global community in return?

### World Leaders Weigh In

Ernesto Zedillo, who served as Mexico's president throughout the 1990s, was among the first to respond. He argued that governments need stronger incentives to act transparently. Drawing on the example of South Africa, which faced punishing travel restrictions in 2021 simply for being the first to identify a new Covid-19 variant, Zedillo challenged the international community to offer real assurances rather than punishment for honesty.

Zeid bin Ra'ad bin Zeid al-Hussein, a former United Nations High Commissioner for Human Rights from Jordan, took a systems-thinking approach. He suggested that health policy architects should look to sectors where verification mechanisms are already robust and use those models as a blueprint for strengthening global disease reporting.

Ellen Johnson Sirleaf, Liberia's former president and Africa's first elected female head of state, offered what may have been the most grounded perspective. She argued that non-compliance with international reporting standards is rarely a matter of bad intent — it is more often a consequence of fragile healthcare infrastructure. Countries that cannot reliably detect or classify an outbreak are also ill-equipped to report it.

"Most times, it is not a lack of political will as much as it is a failure of the systemic capability," Sirleaf said.

---

## Climate, Conflict, and Compounding Crises

Over the course of roughly an hour, the Elders worked through a series of layered scenarios that illustrated how geopolitical tensions, climate-related disasters, and active conflicts can amplify the damage caused by disease outbreaks. The group drew freely on their own experiences managing crises during their years in power.

A second scenario pushed the simulation further. Chad had finally notified the WHO — but only after a two-week delay, by which point the outbreak had already crossed into northern Cameroon. Severe flooding had simultaneously severed transport routes, making it nearly impossible to ship pathogen samples to an international laboratory for analysis. The question for the Elders became: how do global health institutions prepare for health emergencies and climate disasters that are no longer occurring separately, but simultaneously?

Sirleaf was direct in her assessment. "The international integrated system or integrated response is not there yet," she said.

---

## AI Tools and Real-World Emergencies

Before the simulation began, WHO staff walked the Elders through a briefing on how the organization currently supports African nations in detecting and responding to health emergencies. That presentation included an introduction to a new artificial intelligence-powered system designed to enhance real-time decision-making during health crises — a tool that reflects the growing role of technology in epidemic preparedness.

The timing of the exercise was striking. It took place amid an ongoing hantavirus outbreak and, in a development that underscored the urgency of the entire endeavor, just one day before health authorities confirmed a new Ebola outbreak spanning Uganda and the Democratic Republic of the Congo. That outbreak has since claimed at least 139 lives.

---

## A Missing Treaty and a Broken Trust

Hanging over the room was another uncomfortable reality: international negotiators had just missed a critical deadline to finalize a global pandemic treaty — an agreement first proposed during the height of the Covid-19 crisis in 2021. The treaty was intended to establish clear rules for sharing pathogen data between nations and to guarantee equitable access to vaccines, diagnostics, and treatments in return.

The collapse of those talks, even temporarily, reflects a deep fracture in trust between high-income nations and the developing world, particularly across Africa. During the Covid-19 pandemic, wealthy countries secured the lion's share of vaccine supplies, leaving much of the African continent waiting for doses that arrived too late or not at all. For many observers, that experience remains an open wound.

---

## The Case for Multilateralism

Denis Mukwege, a Congolese surgeon specializing in gynecological trauma and a Nobel Peace Prize recipient, reflected on the session's most important takeaway. With firsthand knowledge of how his country has managed repeated Ebola and mpox outbreaks, Mukwege stressed that no nation can afford to face these threats alone.

"We need to work together because we never know where it will happen," he said. "We need to get all the people to be ready when it happens. We need really to understand that when we have the outbreak, it can go far and sometimes it can go beyond our borders."

Dr. Mohamed Janabi, the WHO's Regional Director for Africa, closed the session with a sobering reminder of the scale of the challenge his organization faces every year. In 2023 alone, the WHO recorded 146 disease outbreak emergencies across the African continent.

"You have seen what we face here," Janabi told the gathered leaders. "Outbreaks will continue — how we manage them, that's the issue."

---

For a group of individuals who have already shaped history, Thursday's simulation was less an academic exercise than a dress rehearsal for a threat the world has not yet fully reckoned with.

The Elders, founded by Nelson Mandela, ran a pandemic simulation in Nairobi — exposing critical gaps in global health preparedness and disease response systems.

Former World Leaders Simulate Pandemic Response in Nairobi

large_2781.jpg

medium_2781.jpg

small_2781.jpg

thumbnail_2781.jpg

2781.jpg

Former World Leaders Run a Fake Pandemic Drill in Nairobi — Here's What They Discovered

## Planned Parenthood Introduces Advance Abortion Pill Program in Two States

Residents of Washington state and Hawaii now have access to a groundbreaking new initiative from Planned Parenthood — the option to obtain abortion medications, mifepristone and misoprostol, ahead of time to keep at home in case they need them in the future.

The program, known as **"Just In Case Abortion Pills,"** marks the first time a Planned Parenthood affiliate has offered what medical providers call "advance provision" of abortion medication. The initiative was launched Thursday and was initially shared exclusively with NPR.

### What Is Advance Provision and Why Does It Matter?

Advance provision allows individuals to obtain abortion pills before they are pregnant, storing them for potential use during an early pregnancy. Several telehealth organizations have been offering this service for years, but Planned Parenthood's entry into this space carries significant weight due to its widespread name recognition and the trust patients place in the organization.

"Having a group like Planned Parenthood — one that carries such trust and name recognition — add these services is really important," said Elisa Wells, co-founder of Plan C, a website dedicated to information about medication abortion.

Rebecca Gibron, president and CEO of Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana and Kentucky, explained the reasoning behind the timing: "As evidence supporting this model of care has continued to grow, and with supportive policy environments in Washington and in Hawai'i, this really is the right time for us to step into this space."

### Access Options and Pricing

Unlike most other advance provision services, which operate exclusively online, Planned Parenthood patients in Washington and Hawaii can obtain the medications either through telehealth or in person at any of the organization's 16 health centers across both states.

For patients attending an existing appointment — such as a routine wellness visit or STI screening — the cost to add the abortion pills is **$100**. A standalone appointment runs **$150**, though financial assistance programs are available for those who cannot afford those fees.

Dr. Colleen McNicholas, chief of medical affairs at the same Planned Parenthood affiliate, emphasized that patients would have continued support even long after receiving the pills. "If a patient gets the pills and then goes to use them 11 months later, we are still available to them as their provider to answer those questions," she said.

### Real Experiences: One Woman's Story

Whit, a 29-year-old now living in the Chicago area, first obtained abortion pills in advance four years ago following news about potential restrictions on reproductive rights. She asked NPR to use only her first name due to the personal nature of her decision.

"It kind of all started when the draft of the Roe decision was leaked in May of '22," she recalled. After learning she could order the pills proactively, she obtained them through an international organization called Aid Access.

About a year after storing them, she ended up using the medication shortly after missing her period. "It was literally like a period," she said. "I'm just like, 'Wow, everybody should be able to have that experience. It doesn't have to be this big, treacherous thing.'" She has since reordered and currently keeps a fresh supply at home. The medication typically has a shelf life of approximately two years, with expiration dates printed on the packaging.

### Safety, Legality, and Medical Consensus

Anna Fiastro, a research scientist at the University of Washington School of Medicine, affirmed the strong safety record of the two medications. "These medicines are available over the counter in other countries, and they're very safe, very effective, and can be self-managed," she said, noting that the World Health Organization provides guidance for self-managed use through the first trimester.

Elisa Wells added that it is currently legal for patients to have abortion medication on hand in **49 states**. Louisiana is the sole exception, having classified the medications as controlled substances in 2024.

### Opposition and Political Pushback

Not everyone views this development favorably. Republican Senator Cindy Hyde-Smith of Mississippi, who chairs the Senate Pro-Life Caucus, raised objections during a 2024 congressional hearing. "American women are stockpiling the abortion pills through advanced prescribing from abortion companies and providers," she said, questioning the lack of mandatory physician oversight.

Then-FDA Commissioner Robert Califf responded that physicians have discretion in prescribing decisions, stating: "We don't advocate stockpiling as a method, but we don't regulate the practice of medicine."

Thus far, the Trump administration's FDA has taken limited action to restrict abortion medication access, a point of frustration for anti-abortion advocates. While Congress did temporarily cut Planned Parenthood from Medicaid funding, that funding is set to be reinstated in July unless new legislation is enacted.

### A Growing Trend Amid Legal Uncertainty

Ongoing legal challenges surrounding mifepristone — including a case brought by Louisiana against the FDA over remote prescription rules — have prompted more people to seek abortion pills in advance. The Supreme Court has temporarily paused any immediate changes to access while the case continues through lower courts, but the issue remains unresolved.

Wells of Plan C reports that news of the Louisiana case has triggered a noticeable spike in website traffic and an increase in advance provision requests. "We don't know what the outcome will be, so it might make sense to get pills now in case there is a bad decision in that court case," she said.

Despite the uncertain legal landscape, Wells remains confident in the trajectory of abortion pill access. "Abortion pills are everywhere, they're safe, they're effective, and they're pretty much unstoppable," she said. "The genie is out of the bottle."

Planned Parenthood launches a 'Just In Case' abortion pill program in Washington and Hawaii, letting patients stock mifepristone and misoprostol at home in adva

Planned Parenthood Offers Advance Abortion Pills in Two Stat

large_jpeg

medium_jpeg

small_jpeg

thumbnail_jpeg

jpeg

Planned Parenthood Launches 'Just In Case' Abortion Pill Program in Washington and Hawaii

## A Growing Crisis With No Easy Answer

Infectious disease experts are sounding the alarm over a rapidly expanding Ebola outbreak that the World Health Organization has officially declared a public health emergency. With more than 600 suspected cases and nearly 140 suspected deaths already recorded, the numbers continue to climb daily — and what makes this situation particularly alarming is the strain responsible for it.

The epicenter of the outbreak is a remote province in northeastern Democratic Republic of Congo — a region long battered by violent conflict and limited infrastructure. Two additional cases have also been confirmed in Uganda's capital city. Perhaps most unsettling of all: health officials believe the outbreak may have been quietly spreading for months before anyone detected it.

"This is an example of a perfect storm," says Dr. Abraar Karan, an infectious disease physician and faculty member at Stanford University.

## Where Did This Outbreak Come From?

Ebola outbreaks have historically emerged from either east or west Africa, and the Democratic Republic of Congo has been hit harder than any other nation — this marks its 17th outbreak since 1976. But the exact moment a virus jumps from animals to humans remains difficult to pinpoint.

Scientists believe the most likely route of transmission is through contact with bats — specifically by consuming bat meat or coming into contact with bat droppings, which can occur when workers enter caves or mines. Other animals have also been implicated.

"A number of animals have tested positive for antibodies, including certain types of deer called duiker and non-human primates," explains Dr. Karan, whose research team has been studying Ebola and related viruses in Kenya for several years.

The typical chain of infection begins with a single person contracting the virus from an animal — a process known as spillover — who then passes it on to other humans.

## What Does Ebola Actually Look Like?

Forget what Hollywood has shown you. Dr. Nahid Bhadelia, an infectious disease physician who treated more than 500 Ebola patients during the West Africa outbreak a decade ago, says the reality looks very different from the movies.

"After seeing hundreds of Ebola patients, I have yet to see anyone bleeding out of their eyes," says Bhadelia, who also directs the Boston University Center on Emerging Infectious Diseases.

### Early Symptoms

In its initial stages, Ebola can be deceptively unremarkable. It often resembles other common illnesses like malaria or typhoid, presenting with fever, nausea, and diarrhea — symptoms that make early diagnosis especially difficult in regions where those diseases are already widespread.

### As the Disease Progresses

As the infection advances, the situation becomes far more serious. Patients typically experience severe, often bloody vomiting and diarrhea. The body's own immune response can trigger a dangerous cascade of events, leading to systemic shock and multi-organ failure.

Survival depends heavily on how quickly a patient receives medical attention and the quality of care available. This disparity is starkly illustrated by comparing outcomes: during the West Africa outbreak, mortality rates ranged from 50 to 70% in the field. In contrast, infected patients transported to the United States for advanced medical care saw mortality rates drop below 20%.

## What Makes This Strain Especially Concerning?

Not all Ebola strains are created equal. The current outbreak has been caused by the Bundibugyo strain — a far rarer variant than the Zaire strain responsible for the catastrophic 2014–2016 West Africa epidemic.

The Zaire strain carries a fatality rate of up to 90% when left untreated. The Bundibugyo strain, while still deadly, appears to carry a somewhat lower case fatality rate — estimated between 30 and 50% based on previous outbreaks.

"If there's any upside, the data we have on Bundibugyo from past outbreaks suggests a slightly lower case fatality rate — not comfortingly low, but lower than some other strains," says Dr. Daniel Bausch, a visiting professor at the Geneva Graduate Institute.

### The Vaccine Problem

Here lies the crux of the challenge: there are currently no licensed vaccines or targeted treatments for the Bundibugyo strain. This stands in sharp contrast to the Zaire strain, for which two vaccines and effective monoclonal antibody therapies now exist.

Despite this gap, some experts urge measured optimism. "We've controlled plenty of Ebola outbreaks in the past without vaccines or specific therapeutics," Bausch notes. "It's only recently that those tools have been available for Zaire at all."

Without such options, the response relies on tried-and-true public health measures: rigorous infection control protocols, supportive patient care including rehydration therapy, and thorough contact tracing — the process of identifying and monitoring everyone who may have been exposed to an infected individual.

## How Contagious Is It Really?

Here is where the news gets somewhat more reassuring. Ebola does not spread through the air, making it significantly less contagious than viruses like COVID-19 or measles.

"On average, one person with Ebola infects about two others," says Bhadelia. "Compare that to measles, where one person can infect around 18. Measles is far more transmissible — though the mortality rate of many Ebola strains is much, much higher."

Ebola spreads through direct contact with an infected person's bodily fluids, including blood, saliva, semen, and diarrhea. Crucially, individuals are not contagious until symptoms appear — and the viral load in bodily fluids increases as the disease progresses, making proper protective equipment essential for healthcare workers and home caregivers alike.

## The Bottom Line

The combination of a rare, vaccine-free strain, a conflict-ridden outbreak region, delayed detection, and cases crossing international borders has created conditions that experts are right to take seriously. While the Bundibugyo strain may be slightly less lethal than its Zaire counterpart, the absence of targeted medical tools and the challenging geography make this an outbreak that demands global attention.

A rare Ebola strain is spreading in the DRC with no vaccine available. Learn about symptoms, transmission, fatality rates, and what experts are doing.

Rare Ebola Strain Spreads With No Vaccine: Key Facts

large_png

medium_png

small_png

thumbnail_png

No Vaccine, No Warning: What You Need to Know About the Rare Ebola Strain Spreading Now

## The Hidden Condition Causing Unbearable Pain in Women

At least one in ten women are living with adenomyosis — a debilitating womb condition that triggers heavy bleeding, intense pain, and irregular periods. Despite how widespread it is, many sufferers report that their symptoms are frequently minimized or ignored by those around them, including medical professionals.

One woman described the sensation as feeling like a "chainsaw" working inside her body. It is a striking image, but for many women, it is not far from their daily reality.

## What Exactly Is Adenomyosis?

Adenomyosis occurs when the tissue that normally lines the uterus begins to grow into the muscular wall of the womb itself. While it shares several symptoms with endometriosis, the two conditions are distinct. In endometriosis, cells spread outside the uterus and can appear in various parts of the body. In adenomyosis, the abnormal growth remains confined within the womb.

Mathilde Barker, a 22-year-old content creator from Surrey with over 500,000 followers across TikTok and Instagram, lives with both conditions. She was diagnosed with endometriosis at 19 following keyhole surgery, and with adenomyosis two years later.

"When I was at my worst, it genuinely felt like I had a mass in my uterus and that it was dragging behind me," she said. Her online platforms quickly attracted a community of followers experiencing similar symptoms, highlighting just how many women are silently suffering.

## Real Women, Real Struggles

For Lauren Buckland, 36, the condition brings unpredictable stabbing pains in her uterus, lower back, hips, and pelvis. She recalled breaking down in tears while walking home from work, overwhelmed by pain she could not explain at the time.

"This is my body and it's not working how I'd like it to work, but I've got to work with it," she said. "It's a bit frustrating, but it's just being a woman, isn't it?"

Emma Blackburn, 34, from Broadstairs in Kent, lives with adenomyosis alongside endometriosis and fibromyalgia. She describes sudden waves of pain that feel like labour contractions shooting through her pelvis, and passes blood clots ranging in size from a 5p to a 50p coin with every menstrual cycle.

"I plan my entire life around my cycle," she explained, adding that she wishes the public were better informed about women's health conditions and "the impact they have on both our physical and mental health."

Eleni Moutesidi has endured eleven surgeries related to her gynaecological conditions — a sobering testament to the severity these illnesses can reach when left unaddressed or mismanaged.

## A Government Acknowledgement

A spokesperson from the Department for Health and Social Care acknowledged the scale of the problem, telling the BBC: "It is deeply concerning that so many women feel dismissed when they come forward with pain."

The statement reflects a growing recognition that women's pain has historically been undervalued within healthcare systems, but advocates stress that words must now translate into meaningful action.

## Breaking the Stigma in the Workplace

Beyond the medical setting, adenomyosis and other menstrual health conditions also affect women in professional environments. Lesley Salem, founder of workplace training organisation Over the Bloody Moon, is working to ensure that hormonal and menstrual health does not become a career barrier.

"We want to make sure that hormonal health and menstrual health isn't a barrier," she said, noting that a persistent stigma — particularly for women early in their careers — discourages many from speaking openly about their struggles at work.

Salem believes meaningful change starts with education, and that open, informed conversations about menstrual health need to become the norm across all sectors.

## The Medical Community Calls for Greater Awareness

Healthcare professionals are aligned on one key message: education must come first, and it must start early.

Dr. Rebecca Mallick, a consultant gynaecologist at University Hospitals Sussex, emphasized that people should be talking about menstruation from a young age, so that it becomes common knowledge that periods severe enough to disrupt daily life are not something women simply have to accept.

"It all starts with education on all levels," she said.

### Diagnosis Remains a Major Challenge

Historically, adenomyosis has been extraordinarily difficult to diagnose. For a long time, a hysterectomy — the surgical removal of the uterus — was the only reliable method for confirming the condition. It is also frequently missed on standard imaging scans, meaning countless women go undiagnosed for years.

## The Future: Could a Home Test Kit Be the Answer?

Researchers are now working to change the diagnostic landscape. Dr. Marianne Watters, a clinical researcher with the women's health charity Wellbeing of Women, is investigating whether adenomyosis can be detected through blood samples. If successful, this research could pave the way for an at-home testing kit, allowing women to identify the condition themselves — a development that could dramatically reduce the years-long diagnostic delays so many currently face.

For the millions of women living with adenomyosis, greater awareness, better education, and advances in diagnosis cannot come soon enough. Their pain may be invisible to the eye, but its impact on their lives is anything but.

One in ten women live with adenomyosis, yet many are dismissed. Learn about symptoms, diagnosis challenges, and new research offering hope.

Adenomyosis: Symptoms, Diagnosis and What Women Face

ec680ba0-544e-11f1-bc99-1d37de959855.jpg

Adenomyosis: The Silent Condition Affecting Millions of Women

## Two Dozen States Challenge Trump Administration's Healthcare Loan Restrictions

A coalition of 24 states and Washington, D.C., has filed a federal lawsuit targeting a Trump administration rule that significantly restricts access to federal student loans for graduate students pursuing degrees in nursing, physical therapy, and other critical healthcare fields.

New York Attorney General Letitia James captured the urgency of the coalition's position in a pointed statement: "Higher education is expensive, and our health care system is already under immense strain. This rule will shut talented people out of critical professions and leave communities with fewer health care providers they desperately need."

## What the New Loan Rules Actually Change

The legal battle centers on two interconnected policy shifts that have drawn fierce opposition from healthcare advocacy groups, including the American Nurses Association.

The first change stems from the One Big Beautiful Bill Act, passed by Republicans, which dramatically reduces borrowing limits for graduate students. While undergraduate borrowers — including those in nursing programs — remain unaffected, graduate students now face an annual borrowing cap of $20,500 and a lifetime ceiling of $100,000. Previously, students could borrow up to the full cost of attendance for their program.

### The Professional Degree Exemption Controversy

The second — and more legally contentious — change involves how the Trump administration has defined which graduate programs qualify as "professional degrees," a classification that allows for higher borrowing limits of up to $50,000 annually and $200,000 total.

The administration has narrowed that professional degree designation to just 11 fields: chiropractic, clinical psychology, dentistry, law, medicine, optometry, osteopathic medicine, pharmacy, podiatry, theology, and veterinary medicine. Notably absent from this list are nursing, physical therapy, and nurse anesthesia — fields with significant workforce shortages and growing demand.

The lawsuit argues that the administration "issued a final rule unlawfully narrowing" an established federal definition of professional degrees, imposing restrictions that were never authorized by Congress. Plaintiffs also point out a glaring historical oversight: the department's reference list of professional degree examples was drawn from a regulation last updated in the 1950s — decades before modern graduate nursing and allied health programs even existed.

## Healthcare Advocates Sound the Alarm

The American Nurses Association responded to the finalized rule with sharp criticism. Association President Jennifer Mensik Kennedy warned that the consequences would be felt far beyond university campuses.

"This Department of Education has chosen to make it harder for nurses to advance their education and their careers," Kennedy said. "This rule will be felt in real communities — for example, in rural areas where nurse practitioners, midwives, and nurse anesthesiologists are often the only providers of core care services."

The American Association of Colleges of Nursing echoed these concerns, cautioning that under the new framework, nursing students may be forced to turn to expensive private loans or abandon advanced practice programs altogether.

## A Divided Response: Downplaying the Impact

Not everyone views the restrictions as catastrophic. Preston Cooper, a researcher at the conservative-leaning American Enterprise Institute, argued that the alarm surrounding the rule outpaces its likely real-world effects, suggesting the caps would only meaningfully impact a narrow range of programs with unusually high tuition costs.

The Education Department itself noted that the vast majority of the nursing workforce — approximately 80% — does not hold a graduate degree, and that the changes leave undergraduate nursing pathways completely intact.

## Education Secretary McMahon Faces Bipartisan Pressure

Despite those defenses, the rule has generated rare bipartisan pushback. During a recent appearance before the House education committee, Education Secretary Linda McMahon was challenged by Republican Representative Randy Fine of Florida, who questioned whether limiting loans in a field already facing critical shortages was sound policy.

McMahon offered a two-part defense: first, that the cost of most advanced nursing degrees would still fall within or close to the new caps; and second, that the borrowing limits are designed to pressure colleges into reducing their tuition.

"It is our overall goal to bring down the cost of college and education," McMahon told lawmakers. "If we can bring down the cost for nurses in schools, we can get more students to apply."

Whether universities will respond by lowering tuition — or whether students will simply be left with fewer options — remains to be seen. Until that question is answered, both borrowers and policymakers will be watching closely.

24 states are suing the Trump administration over new federal student loan limits that restrict graduate nursing and healthcare degree borrowing.

States Sue Over Federal Loan Caps on Nursing Degrees

24 States Take Legal Action Against Federal Loan Caps Threatening Healthcare Education

## How Extreme Heat Affects Your Body

Summer heatwaves are more than just uncomfortable — they can be genuinely dangerous. While hot weather poses some level of risk to everyone, certain groups are significantly more vulnerable to serious health consequences. Understanding what heat does to the body is the first step toward protecting yourself and those around you.

## What Happens Inside Your Body When Temperatures Rise

As your body temperature climbs, your blood vessels begin to dilate, allowing more blood to flow closer to the skin's surface. This natural cooling response has a side effect: it lowers your blood pressure, forcing your heart to pump harder to keep circulation going.

At the same time, your body ramps up sweat production. As that sweat evaporates from the skin, it carries significant heat away with it — a highly effective cooling mechanism. However, sweating also depletes your body's fluid and salt reserves, and the balance between these two becomes disrupted over time.

Together, reduced blood pressure and fluid loss can trigger a range of symptoms, from minor irritations like heat rash and swollen feet to more serious conditions like heat exhaustion.

### Signs of Heat Exhaustion

Heat exhaustion occurs when the body's cooling systems begin to struggle. Common symptoms include heavy sweating, dizziness, nausea, headache, and fatigue. If someone around you shows these signs, move them to a cool environment, offer water, and apply cool, damp cloths to the skin.

If the person does not show improvement within 30 minutes, the situation escalates to a medical emergency. At that point, they may be experiencing **heatstroke** — and you should call emergency services immediately.

## When Heat Becomes Life-Threatening

The human body works hard to maintain a core temperature of approximately 37°C, regardless of external conditions. In extreme heat, however, that balance becomes increasingly difficult to sustain.

Heatstroke occurs when the body's temperature exceeds 40°C and its cooling mechanisms fail entirely. A person experiencing heatstroke may stop sweating despite being dangerously overheated, and can suffer seizures or loss of consciousness. This is a critical medical emergency requiring immediate professional intervention.

If blood pressure falls too severely during any stage of heat illness, the risk of cardiac events — including heart attacks — increases substantially.

## Who Is Most at Risk?

While anyone can be affected by extreme heat, certain individuals face a heightened level of danger:

- **Older adults** may have a reduced ability to regulate body temperature and are more likely to have underlying health conditions.
- **Babies and young children** cannot effectively communicate distress and are particularly susceptible to overheating.
- **People with chronic conditions** such as heart disease or diabetes face compounded risks. Diabetes, for instance, can accelerate fluid loss and interfere with the body's ability to sweat.
- **Those with neurological conditions** like dementia may not recognise heat as a threat or be able to take steps to cool down.
- **Less mobile individuals** may struggle to move to cooler environments.
- **People experiencing homelessness** face prolonged sun exposure with limited access to shade or cooling resources.
- **Residents of top-floor apartments** often deal with higher indoor temperatures due to heat rising through the building.

## Medications and Heat: What You Need to Know

Certain commonly prescribed medications can interact dangerously with high temperatures. The NHS advises patients to continue taking their medication as prescribed while placing extra emphasis on staying cool and well-hydrated.

Here's how some medications can become more risky in the heat:

- **Diuretics (water pills)**, often prescribed for heart failure, increase fluid loss — heightening the risk of dehydration and dangerous mineral imbalances.
- **Antihypertensives** (blood pressure-lowering drugs) can compound the natural drop in blood pressure caused by heat, potentially leading to dangerously low levels.
- **Certain epilepsy and Parkinson's medications** may inhibit the body's ability to sweat, undermining its primary cooling method.
- **Drugs such as lithium and statins** can reach unsafe concentrations in the bloodstream when fluid levels drop significantly.

## Key Safety Precautions During a Heatwave

Experts from the UK Health Security Agency (UKHSA) recommend checking in regularly on those who may have difficulty staying cool — particularly elderly neighbours, people with underlying health conditions, and those living alone.

Additionally:

- **Never leave children, pets, or vulnerable adults in a locked vehicle**, even briefly. Temperatures inside a stationary car can soar within minutes.
- **Avoid swimming in rivers or open water** unless you are confident it is safe — hidden hazards make this especially risky.
- **Stay hydrated** and avoid excessive physical exertion during peak heat hours.

## The Deadly Toll of Extreme Heat

The scale of heat-related harm is starkly illustrated by the summer of 2022 in England, when temperatures reached a record-breaking 40.3°C. That year saw an estimated **2,985 excess deaths** attributed to the heat — the highest figure ever recorded in a single year. These numbers serve as a sobering reminder that heatwaves are not simply inconveniences but genuine public health emergencies.

Staying informed, prepared, and attentive to those around you can make a life-saving difference when temperatures soar.

Discover what extreme heat does to your body, who faces the greatest risk during heatwaves, and how certain medications can make the danger worse.

How Extreme Heat Affects Your Body and Your Health

3ac64500-4c12-11f0-9800-55e1c62425e5.jpg

How Extreme Heat Affects Your Body — And Who Faces the Greatest Risk

## A New Frontier in Depression Treatment

For the millions of people living with depression that simply refuses to respond to conventional medication, a groundbreaking early clinical trial may signal the beginning of a new era in psychiatric care. Researchers at the University of Bristol have found that an immunotherapy drug — already well-established in treating inflammatory conditions — could hold significant promise for patients with treatment-resistant depression.

## The Drug at the Center of the Research

The medication in question is tocilizumab, an anti-inflammatory agent widely prescribed for autoimmune disorders like rheumatoid arthritis. It works by blocking the IL-6R receptor, effectively preventing inflammatory signals from binding to cells and triggering the immune responses associated with autoimmune disease. Scientists now believe this same mechanism may play a meaningful role in alleviating depressive symptoms, particularly in patients whose biology is linked to chronic inflammation.

## Why This Matters for Depression Sufferers

Depression is far more prevalent — and far more complicated — than many people realize. Approximately one in six adults in the UK will experience moderate to severe depressive symptoms at some point in their lives. Alarmingly, around one in three people diagnosed with depression fail to improve with standard treatments, which predominantly work by targeting neurotransmitter activity in the brain. For these individuals, the current medical toolkit offers frustratingly limited options.

## How the Trial Was Conducted

The clinical trial enrolled 30 participants, all of whom had been diagnosed with moderate to severe depression and had not responded adequately to conventional antidepressants. Over a four-week period, participants were randomly assigned to receive either tocilizumab or a placebo injection. Researchers then tracked changes across multiple well-established measures of mental health and wellbeing.

### What the Results Revealed

While the study's small sample size meant that statistically definitive conclusions were limited, the directional findings were notably encouraging. Participants treated with tocilizumab consistently showed greater improvements over time compared to those in the placebo group. These improvements spanned several key areas, including:

- **Overall depression severity**
- **Fatigue levels**
- **State anxiety**
- **General quality of life**

Perhaps most compellingly, 54% of patients who received tocilizumab achieved depression remission, compared to just 31% in the placebo group. This translated to a Number Needed to Treat (NNT) of 5 — meaning just five patients would need to be treated for one to experience meaningful recovery. For context, the NNT for SSRIs, the most commonly prescribed first-line antidepressants, sits at approximately 7, suggesting immunotherapy could outperform existing treatments in appropriately selected patients.

## Expert Voices on the Findings

Professor Golam Khandakar, a psychiatry and immunology expert at Bristol Medical School and the study's senior author, described the trial as an **"important milestone"** in the pursuit of new therapeutic options for hard-to-treat depression.

"This is one of the first randomised controlled trials to test immunotherapy for depression, the first to test IL-6R as the treatment target, and the first to use a targeted approach to select patients most likely to benefit — and to show that it works," Professor Khandakar stated.

Dr. Éimear Foley, a senior research associate in immunopsychiatry at the MRC Integrative Epidemiology Unit and co-author of the study, emphasized the broader implications for personalized medicine in mental health care.

"Depression is estimated to affect around 10 to 20 percent of people worldwide during their lifetime, yet for many patients current treatments do not work well enough," Dr. Foley explained. "Our study moves us closer to more tailored depression care, where treatments are chosen to better fit a person's biology. This will help us provide the right treatment to the right patients at the right time."

## What Comes Next

Researchers are clear that while these findings are early and based on a small participant group, they lay an important foundation for larger, more comprehensive trials. The study represents a meaningful shift in how scientists are thinking about depression — not purely as a chemical imbalance in the brain, but potentially as an inflammatory condition in some patients, one that may respond to an entirely different class of medication.

For the growing number of people worldwide for whom antidepressants have offered little relief, this research offers something increasingly rare: genuine reason for optimism.

UK scientists find tocilizumab, an arthritis immunotherapy drug, may help treat antidepressant-resistant depression. Discover what early trial results reveal.

Immunotherapy for Depression: Early Trial Shows Promise

large_2917.jpg

medium_2917.jpg

small_2917.jpg

thumbnail_2917.jpg

2917.jpg

Could Immunotherapy Be the Breakthrough Depression Treatment We've Been Waiting For?

## The Case for Arts Engagement in Health and Education

The growing body of evidence linking arts participation to improved health outcomes should surprise nobody who has spent meaningful time working alongside children, young people, or marginalized communities. Two prominent voices in the UK creative sector are now calling on policymakers to take bold, coordinated action — connecting the dots between education, culture, and public health before the opportunity is lost.

## Creative Experiences Help Children Feel Seen and Valued

Paula Briggs, founder of AccessArt — a UK charity established nearly three decades ago to champion visual arts education — reports that teachers across the country consistently share the same message: creative learning helps children feel connected, empowered, and genuinely engaged with school life.

Despite this, arts subjects have been systematically undervalued in many schools for years. The relentless pressure to narrow the curriculum and prioritize outcomes that can be easily measured has pushed meaningful creative engagement to the margins.

This comes at a significant cost. England continues to grapple with persistently high rates of school absence, and behind every statistic is a child who may simply not feel they belong. While arts education alone cannot resolve the complex causes of school disengagement, it can play a meaningful role in transforming schools into spaces where young people feel recognized, respected, and motivated.

### Arts Education Is Not Optional — It Is Essential

Briggs argues that treating creative learning as an expendable add-on while simultaneously expressing concern about children's mental health and school disengagement represents a fundamental contradiction in policy thinking.

Creating time within the school day for imagination, making, and cultural connection is not an indulgence. It is a foundational investment in healthier children and stronger communities. Policymakers, she urges, must be far braver in aligning education, culture, and health agendas into a single, coherent strategy.

## Unequal Access to the Arts Is Driving Health Inequality

Recent research from University College London has reinforced the connection between arts engagement and slower biological aging — a finding that carries serious implications for public health planning. For Nicky Goulder, Founding CEO of Create — a charity she established in 2003 to bring creative opportunities to society's most excluded individuals — the research underlines an urgent and uncomfortable truth: access to the arts is far from equal.

Decades of academic study have consistently demonstrated that engaging with creative disciplines — whether painting, singing, dancing, writing, or any other artform — can significantly enhance both physical and mental wellbeing. Yet people from lower socioeconomic backgrounds and otherwise disadvantaged communities remain far less likely to benefit from these opportunities than their more affluent counterparts.

### Bringing Creativity to Those Who Need It Most

Create addresses this gap directly by delivering artist-led creative workshops entirely free of charge, held in locations that participants already know and trust. After more than twenty years of evaluation data, the charity's findings are clear: giving people access to creative expression measurably improves their confidence and wellbeing.

Crucially, the positive transformations tend to be most profound among those who face the greatest disadvantage — precisely the individuals who would otherwise have no meaningful access to creative life.

## A Call for Systemic Change

Goulder warns that if society fails to address this deep imbalance, unequal access to the arts will simply become another layer of health inequality, further entrenching disadvantage rather than alleviating it.

The evidence is in. Creative engagement improves lives across every age group, and the benefits are greatest for those who have been left furthest behind. What is now needed is the political will to ensure that arts participation is treated not as a privilege for the few, but as a right — and a genuine vehicle for wellbeing and opportunity — for everyone.

Experts reveal how creative arts education supports children's wellbeing and school attendance, while tackling health inequality in disadvantaged communities.

How Arts Engagement Boosts Mental Health at Every Age

large_6020.jpg

medium_6020.jpg

small_6020.jpg

thumbnail_6020.jpg

6020.jpg

How Arts Engagement Supports Mental Health and Wellbeing Across All Ages

That&#039;s the provocative question that researchers dug into after the U.S. shut down its premier aid agency.

Refugees carry food at a distribution center run by the World Food Programme at Kakuma Refugee Camp in Turkana, Kenya. After U.S. aid that paid for the food was curtailed, protests broke out. Andrew Kasuku/AP hide caption

Does foreign aid have an impact on violence — on wars, on street fights, on random attacks?

The answer is that yes, it does — in two opposite, and perhaps counterintuitive, ways. On the one hand, aid can provide jobs and resources. And that, in turn, can reduce the incentives for people to engage in violent actions.

Yet it can have the reverse effect as well. "Aid can also increase conflict by introducing something to fight over," says Austin Wright , a data scientist at the University of Chicago who works at the intersection of public policy and statistics. He's referring to resources like roads and supplies paid for by the foreign assistance. In other words, "things that are of value to control."

The termination of USAID — America's premiere aid agency — gave researchers another angle to explore. Does the sudden withdrawal of aid funding have an impact on conflict?

In a study published in the journal Scienc e , Wright and his colleagues conclude that the abrupt dismantling of USAID led to an uptick in overall conflict in places within Africa that have received aid compared to those that have not.

"The rapid collapse of what is probably the most sophisticated humanitarian assistance program in human history had enormous consequences on the ground, undermining livelihoods and therefore leading to a surge in violence," Wright concludes.

The near instantaneous evaporation of assistance "took away the livelihoods, it undermined economic productivity," he explains, thereby weakening the incentives that people might have to refrain from violence. And at the same time, "it did not yet eliminate what the actors were fighting over. And so this is what creates the chaos and the violence that we end up observing."

By way of example, Wright refers to protests that broke out at the Kakuma refugee camp in northwest Kenya in July 2025. The roughly 300,000 refugees there depended on food and other services paid for by USAID. Wright says, "After the cuts, food distributions were sharply reduced, and refugees took to the streets," throwing rocks and setting things on fire. One person was killed. "It is exactly the kind of incident our results capture."

NPR reached out to the U.S. State Department for comment. Spokesperson Tommy Pigott replied in part, "One of the biggest problems with this 'report' is that it fundamentally ignores what is actually happening in Africa. The Trump administration has made unprecedented progress towards the advancement of peace on the continent. Unlike the previous administration … the Trump administration has reinvigorated our assistance programs to focus on efficiency, effectiveness, and partnership."

The researchers considered a map of USAID funds disbursed at the state or provincial level preceding the termination of the agency.

"And then we overlay that with conflict activity," he says, in the form of armed clashes, protests, riots and violence against civilians. These data from the ten months before and after early 2025 came from a detailed independent database of violent conflict called the Armed Conflict Location and Event Data . "So we don't just see that a conflict occurred in a place," Wright says. "We see exactly when the conflict occurred."

And they looked to see how any change in that violent activity may have corresponded to the elimination of USAID investments.

The team found that places that once received more assistance tended to experience more conflict once that aid abruptly disappeared, often because those who had relied on that aid had become more vulnerable to recruitment by armed groups. "When aid is withdrawn suddenly, the economic opportunities disappear fast: wages dry up, clinics close, food programs stop," explains Wright.

"But the things worth fighting over (infrastructure, territory, political power, ethnic grievances, geopolitical tensions) don't vanish overnight," he continues. That meant that in the short term, loss of opportunities, alongside an animation of the individual motivations to fight, caused violence to increase.

In addition, the conflict included combat between armed groups, public demonstrations that spontaneously turned hostile, and deliberate acts of violence that targeted noncombatants — such as rebels attacking a village.

Wright thinks of the conflict arising in environments that are low on economic opportunity but high on grievance. "This is an arrow that points directly at the timing of the shutdown," he says.

The one exception that he and his colleagues found was in places with government that support stronger constraints on the executive leader. These are "settings where the president or equivalent actor cannot unilaterally declare war [or] bypass elected congressional bodies," says Wright.

Such institutions helped their constituents weather the storm of the sudden funding withdrawal. This meant that there was less of an impact on conflict there. Wright cites Nigeria's $200 million supplementary health budget and South Africa's decision to help cover gaps in AIDS and HIV treatment as two examples.

Researchers not involved in the study caution this is a challenging topic to study. "Conflict and the sources of conflict — it's very complex," says Andy Solow , a statistician at the Woods Hole Oceanographic Institution who wasn't involved in the study. "I think it's just generally speaking difficult to get a definitive answer. But you do the best you can, and I think that they did."

Solow did raise a couple concerns with the analysis, including that conflict can be contagious, allowing it to spread. This means that perhaps the individual violent events that the researchers were taking note of in their analysis may have been interrelated.

"Those are technical issues," he says. "But they're not likely to overturn the basic result, which is that the cutoff led to an increase in conflict. I believe their results. They're convincing."

As the authors point out, the increase in violence may well be the legacy of the decision to terminate USAID suddenly. It's a reality that Wright says is concerning since "recent conflict is the single best predictor of future conflict. Once violence escalates, it tends to be self-reinforcing."

That means that even if the aid were to be resurrected, the situation is unlikely to improve as suddenly as it unraveled. That is, says Wright, "the damage from this period of increased violence would not simply undo itself."

That&#039;s the provocative question that researchers dug into after the U.S. shut down its premier aid agency.

A study investigates: Did the abrupt end of USAID have an im

A study investigates: Did the abrupt end of USAID have an impact on violence?

## A Bond That Goes Beyond Companionship

When Stephen O'Callaghan first brought home a German shepherd puppy named Nya, he had no idea she would one day become a trailblazer in the world of therapy animals. From the very beginning, Nya displayed an exceptionally calm and gentle temperament — qualities that would eventually make her the perfect candidate for therapeutic work.

By the time Nya reached five years old, Stephen decided to register her with **Pets As Therapy**, a well-respected organisation that places trained therapy animals in hospitals, care homes, schools, and community settings to help reduce stress, anxiety, and emotional distress.

## A First for the Rail Industry

Stephen works as the Safeguarding and Crime Prevention Lead for TransPennine Express (TPE), and it wasn't long before he recognised an opportunity to bring Nya's calming presence into his professional world. Today, Nya holds the official title of TPE's registered therapy dog — making TransPennine Express the **first train operator in the UK to have its own dedicated therapy dog**.

It's an achievement Stephen is enormously proud of. Travel anxiety and depression affect a significant number of passengers, and Nya's presence at awareness events across the rail network has proven to be a genuinely powerful tool for emotional support.

### Changing Lives One Interaction at a Time

The impact Nya has on people is both immediate and profound. At one mental health awareness event, a woman who had been struggling with low mood spent nearly 20 minutes on the floor with Nya — stroking her fur, cuddling her, and simply being present with her. Afterward, the woman told Stephen that the interaction had genuinely helped break her cycle of negative thinking.

Stories like this are not uncommon. Time and again, people walk away from meeting Nya saying that the encounter made their day measurably better. She has a rare ability to uplift those around her and spark conversations that might not have happened otherwise.

## A Celebrity in Her Own Right

With her striking wolf-like appearance, Nya naturally draws attention wherever she goes. Strangers regularly stop Stephen on the street just to admire her, and she's something of a local celebrity in her community. She accompanies Stephen on school runs with his two young children and has even participated in school presentations — including one in Manchester that ended with a spontaneous tricks showcase that earned her a well-deserved round of applause.

Nya's repertoire of skills is impressive: she can weave continuously between Stephen's legs while walking or running, spin on command, roll over, and jump with both paws. She's also highly food-motivated, and Stephen jokes that she quietly hopes every person they meet has a dog biscuit tucked away — though he always keeps a generous supply on hand just in case.

## Healing Goes Both Ways

While Nya's work focuses on helping others, Stephen is candid about the ways she has supported him personally. After spending **20 years as a police officer** — a career that exposed him to countless traumatic and difficult situations — Stephen knows firsthand what emotional strain can feel like. Walking Nya helps him decompress, stay grounded, and manage the anxiety he occasionally experiences.

In many ways, registering Nya as a therapy dog was Stephen's way of channeling his own difficult experiences into something meaningful for others.

### An Unbreakable Connection

The bond between Stephen and Nya is deep and intuitive. He describes their relationship as one where they genuinely read each other's emotional energy — a quiet, mutual understanding that goes beyond typical pet ownership. Nya follows him from room to room, a devoted shadow who notices his every movement.

"It's nice to have someone miss you when you leave the room," Stephen reflects — and in Nya, he has exactly that.

For the passengers whose days she brightens, the students who cheer her tricks, and the individuals who find a moment of peace in her gentle presence, Nya is far more than a pet. She is a reminder of the extraordinary comfort animals can offer — and proof that sometimes, the most effective therapy has four legs and a wagging tail.

Meet Nya, the German shepherd therapy dog transforming mental health support on the UK rail network and bringing comfort to people everywhere she goes.